Abstract:BackgroundThe aim of this study was to assess the efficacy of a fixed nitrous oxide/oxygen mixture for the management of breakthrough cancer pain. Methods/designA double-blind, placebo-controlled, randomized clinical trial was undertaken in the Medical ward of Tumor Hospital of General Hospital of Ningxia Medical University. 240 cancer patients with breakthrough pain were recruited and randomly received a standard pain treatment (morphine sulphate immediate release) plus a pre-prepared nitrous oxide/oxygen mixture, or the standard pain treatment plus oxygen. The primary endpoint measure was the numerical rating scale (NRS) score measured at baseline, 5 and 15min after the beginning of treatment, and at 5min post treatment. ResultIn all, analysis of pain score (NRS) at 5min after the beginning of treatment shown a significant decrease in nitrous oxide/oxygen mixture treated patients with 2.81.3 versus 5.51.2 in controls (p<0.01). At 15min during the intervention, the mean pain score for nitrous oxide/oxygen was 2.0 +/- 1.1 compared with 5.6 +/- 1.3 for oxygen (p<0.01). ConclusionThis study shows that self-administered nitrous oxide/oxygen mixture was effective in reducing moderate to severe breakthrough pain among patients with cancer. SignificanceThe management of breakthrough cancer pain is always a challenge due to its temporal characteristics of rapid onset, moderate to severe in intensity, short duration (median 30-60min). Our study find that self-administered nitrous oxide/oxygen mixture was effective in reducing moderate to severe breakthrough cancer pain.

Nitrous Oxide/oxygen Mixture for Analgesia in Adult Cancer Patients with Breakthrough Pain: A Randomized, Double-Blind Controlled Trial.